Nicox
Contact us
  • English
  • French
  1. About NicOx
    • Who we are
    • Partnerships
    • Working with us
    • Where we are
    • Contact us
  2. Products
    • AdenoPlus
  3. R&D
    • Ophthalmic pipeline
    • Other therapeutic areas
    • Research platform
    • Clinical trials
  4. Care Areas
    • Ophthalmic disorders
    • Other therapeutic areas
  5. Investor Information
    • Stock information
    • Financial information
    • Annual report
    • Shareholder meetings
    • Fund raising operations
    • Corporate governance
    • Regulated information
  6. News & Media
    • News
    • Press Releases
    • Presentations & Webcasts
    • Events
  1. Home
  2. Investor Information
  3. Regulated information
  1. Stock information
    • Analyst coverage
  2. Financial information
    • Balance sheet and P & L
    • Financial Calendar
    • Presentation of financial results
  3. Annual report
  4. Shareholder meetings
  5. Fund raising operations
  6. Corporate governance
  7. Regulated information
    • Financial information
    • Voting rights
    • Share repurchase programs
    • Alerts (prospectus)
    • Press Releases
    • Alerts (shareholder meetings)

Regulated information

Information provided for under article 221-1 of the 'règlement général de l'AMF'

  • Financial Information (yearly, half-yearly, quarterly)
  • Voting rights and number of shares composing the share capital
  • Share repurchase programs
  • Alerts on past prospectus availability
  • Press releases
  • Alerts on availability of documents pertaining to past shareholder meetings

Nicox ©2012, all right reserved

  1. Contact us
  2. About Nicox
  3. Legal notice and general information
  4. Sitemap

Date month and day: 21/05/2013